Heat Biologics

26.11.2018

ZAG-S&W represented A.G.P./Alliance Global Partners, as underwriter’s counsel, in a $13.8 million offering of common stock and warrants issued by Heat Biologics (NASDAQ: HTBX).

Heat Biologics is a biopharmaceutical company developing immunotherapies designed to activate a patient’s immune system against cancer.

The New York-based ZAG-S&W team included Oded Har-Even and Rob Condon.

 

Recent Activity